Requiring the Prescription Drug Monitoring Program to provide prescription monitoring data to authorized users, rather than the authorized administrator, of another state's prescription drug monitoring program; repealing the termination date of the Program; repealing the requirement that the Department of Legislative Services conduct a certain evaluation of the Program under the Maryland Program Evaluation Act; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2019
( 21-2A-06, 21-2A-10 )
( 8-403 )
Last Updated: 2/3/2020 2:33 PM